In fact, one study showed that hyperactive NRF2 causes metabolic reprogramming of the mouse esophagus through the transcriptional regulation of some metabolic genes, inducing enhanced activity in the glycolytic pathway; blocking glycolysis transiently inhibits the proliferation of human ESCC cells [89]. This evidence concerns the gene NFE2L2 and esophageal squamous cell carcinoma.